Chief Scientific Officer, Medicines Discovery Catapult, Alderley Park, UK
With a longstanding commitment to innovation and collaboration in early drug discovery, Peter Simpson has held numerous drug discovery leadership roles throughout his career. Passionate about disruptive, collaborative innovation to secure new medicines for patients, Simpson supports Medicines Discovery Catapult’s mission to act as champion for drug discovery and technology small- and medium-sized enterprises. An active SLAS contributor, Simpson currently serves as SLAS Discovery’s reviews editor, commissioning insightful reviews on new drug targets and technology advances. Simpson earned a Ph.D. in cell physiology and pharmacology from the University of Leicester, Leicester, UK.